The Client
- Korea-based biopharmaceutical corporation specializing in global biologics development in oncology and rare disease
- Engaged in new medical technology and pharmaceuticals, such as their drug delivery system
Challenge
- The company was seeking to identify and engage potential partners for development of drug delivery system in oncology and SARS CoV2 vaccine spaces
- The company was pursuing external advice on scope and terms, deal structure and negotiation tactics for potential partnerships
Approach
- Assessment of client program’s value proposition and differentiation and deal benchmarking to determine client’s defendable deal structure and value
- Review of term sheets and recommendations for counter proposal
Valued Outcome
- Understanding of program value relative to competitive programs and deal benchmarks
- Expert insights re in-hand term sheets and suggestions for countering
- Strategies for successful deal negotiations